JW (Cayman) Therapeutics Co. Ltd (2126.HK) - Stock Prices, Stock Peers & Analysis

Home
2126.HK

Company Name	JW (Cayman) Therapeutics Co. Ltd
Symbol	2126.HK
Currency	HKD
Price	1.42
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	574,534,685
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	1.19 - 3.49
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Yiping Li M.D.
Website	https://www.jwtherapeutics.com

An error occurred while fetching data.

About JW (Cayman) Therapeutics Co. Ltd

JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, focuses on developing, manufacturing, and commercializing cell-based immunotherapies for hematological cancers and solid tumors. The company offers cell-based immunotherapies, including CAR-T treatments, which is a treatment method that uses human immune cells to fight cancer. Its lead product candidate